CNS Pharmaceuticals
$2.169876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.16 (+8.00%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell CNSP and other stocks, options, ETFs, and crypto commission-free!
About CNSP
CNS Pharmaceuticals, Inc. Common Stock, also called CNS Pharmaceuticals, is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Read More Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Employees
5
Headquarters
Houston, Texas
Founded
2017
Market Cap
35.53M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
92.40K
High Today
$2.16
Low Today
$1.92
Open Price
$2.00
Volume
26.64K
52 Week High
$5.69
52 Week Low
$1.26
Collections
CNSP Earnings
-$0.17
-$0.11
-$0.06
$0.00
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, After Hours